Zeba Siddiqi

555 total citations
31 papers, 394 citations indexed

About

Zeba Siddiqi is a scholar working on Infectious Diseases, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Zeba Siddiqi has authored 31 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Zeba Siddiqi's work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Zeba Siddiqi is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Zeba Siddiqi collaborates with scholars based in India, Ireland and Brazil. Zeba Siddiqi's co-authors include Ritu Karoli, Jalees Fatima, Farzana Mahdi, Syed Tasleem Raza, Faizan Haider Khan, Mohammad Abbas, Sushma Verma, Israr Ahmad, Shania Abbas and Sahabjada Siddiqui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medical Virology and Infection Genetics and Evolution.

In The Last Decade

Zeba Siddiqi

27 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeba Siddiqi India 10 185 124 66 49 32 31 394
Xiaowei Wu China 10 333 1.8× 33 0.3× 142 2.2× 70 1.4× 34 1.1× 17 563
Xiuqin Hong China 10 95 0.5× 43 0.3× 76 1.2× 27 0.6× 13 0.4× 29 363
José Israel León-Pedroza Mexico 8 57 0.3× 39 0.3× 70 1.1× 34 0.7× 31 1.0× 10 337
Vibhuti Kumar Shah India 7 259 1.4× 28 0.2× 127 1.9× 10 0.2× 10 0.3× 8 557
Ram Venkatesh Anantha Canada 10 49 0.3× 39 0.3× 124 1.9× 27 0.6× 12 0.4× 21 548
Arif Duran Türkiye 9 92 0.5× 26 0.2× 42 0.6× 25 0.5× 9 0.3× 45 342
Tracy Snyman South Africa 13 137 0.7× 53 0.4× 41 0.6× 21 0.4× 37 1.2× 29 392
Erhan Palaoğlu Türkiye 9 93 0.5× 75 0.6× 43 0.7× 5 0.1× 10 0.3× 16 312
Andrés Castillo Chile 7 120 0.6× 19 0.2× 60 0.9× 73 1.5× 48 1.5× 11 323
Renato Demarchi Foresto Brazil 8 61 0.3× 37 0.3× 33 0.5× 13 0.3× 15 0.5× 35 262

Countries citing papers authored by Zeba Siddiqi

Since Specialization
Citations

This map shows the geographic impact of Zeba Siddiqi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeba Siddiqi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeba Siddiqi more than expected).

Fields of papers citing papers by Zeba Siddiqi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeba Siddiqi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeba Siddiqi. The network helps show where Zeba Siddiqi may publish in the future.

Co-authorship network of co-authors of Zeba Siddiqi

This figure shows the co-authorship network connecting the top 25 collaborators of Zeba Siddiqi. A scholar is included among the top collaborators of Zeba Siddiqi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeba Siddiqi. Zeba Siddiqi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raza, Syed Tasleem, et al.. (2025). Pharmacokinetics and lipid-lowering efficacy affected by polymorphisms in genetic variability in statin therapy. Egyptian Journal of Medical Human Genetics. 26(1).
4.
Raza, Syed Tasleem, et al.. (2023). Association of the circulating micro-RNAs with susceptible and newly diagnosed type 2 diabetes mellitus cases. SHILAP Revista de lepidopterología. 5. 57–67. 7 indexed citations
5.
Siddiqi, Zeba, et al.. (2023). Interactions between diabetic and hypertensive drugs: a pharmacogenetics approach. Molecular Genetics and Genomics. 298(4). 803–812. 1 indexed citations
6.
Verma, Sushma, Faizan Haider Khan, Zeba Siddiqi, et al.. (2022). Genetic polymorphisms of IL6 gene –174G > C and –597G > A are associated with the risk of COVID‐19 severity. International Journal of Immunogenetics. 50(1). 5–11. 13 indexed citations
7.
Abbas, Mohammad, Sushma Verma, Sahabjada Siddiqui, et al.. (2021). Association of GSTM1 and GSTT1 gene polymorphisms with COVID‐19 susceptibility and its outcome. Journal of Medical Virology. 93(9). 5446–5451. 33 indexed citations
8.
Srivastava, Saurabh, et al.. (2021). A Clinical Study to Evaluate the Association Between Metabolic Syndrome and Sensorineural Hearing Loss. Indian Journal of Otolaryngology and Head & Neck Surgery. 73(3). 346–350. 2 indexed citations
9.
Karoli, Ritu, et al.. (2021). Study of Association of Metabolic Syndrome and Risk Factors of Nephrolithiasis.. PubMed. 69(1). 32–35. 4 indexed citations
10.
Verma, Sushma, Mohammad Abbas, Faizan Haider Khan, et al.. (2021). Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients. Infection Genetics and Evolution. 91. 104801–104801. 68 indexed citations
12.
Mir, Snober S., et al.. (2019). No association of SNP 313A→G inGSTP1with nephropathy, hypertension and dyslipidemia in type 2 diabetes mellitus.. British Journal of Biomedical Science. 76(3). 153–155. 3 indexed citations
13.
Mir, Snober S., et al.. (2018). Role of variants rs5030717 and rs5030718 of TLR4 in the risk prediction of nephropathy, hypertension and dyslipidaemia in type 2 diabetes mellitus. British Journal of Biomedical Science. 75(4). 163–168. 11 indexed citations
14.
Raza, Syed Tasleem, Shania Abbas, Zeba Siddiqi, & Farzana Mahdi. (2017). Association between ACE (rs4646994), FABP2 (rs1799883), MTHFR (rs1801133), FTO (rs9939609) Genes Polymorphism and Type 2 Diabetes with Dyslipidemia.. PubMed. 6(2). 121–130. 23 indexed citations
15.
Karoli, Ritu, et al.. (2017). Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as early markers of diabetic nephropathy. Annals of African Medicine. 16(3). 101–101. 23 indexed citations
16.
Karoli, Ritu, et al.. (2016). Study of vitamin D status in patients with dilated cardiomyopathy at a teaching hospital in North India. Journal of Cardiovascular Echography. 26(3). 89–89. 6 indexed citations
17.
Rizvi, Saliha, Syed Tasleem Raza, Zeba Siddiqi, Shania Abbas, & Farzana Mahdi. (2015). Association of Angiotensin-Converting Enzyme and Glutathione S-Transferase Gene Polymorphisms with Body Mass Index among Hypertensive North Indians. Sultan Qaboos University medical journal. 15(4). e477–e485. 5 indexed citations
18.
Karoli, Ritu, et al.. (2015). Assessment of Noninvasive Risk Markers of Subclinical Atherosclerosis in Premenopausal Women with Previous History of Gestational Diabetes Mellitus. SHILAP Revista de lepidopterología. 16(1). 13–13. 16 indexed citations
19.
Karoli, Ritu, et al.. (2012). Study of early atherosclerotic markers in women with polycystic ovary syndrome. Indian Journal of Endocrinology and Metabolism. 16(6). 1004–1008. 24 indexed citations
20.
Karoli, Ritu, et al.. (2012). Status of periodontal health in patients with type 2 diabetes mellitus at a teaching hospital of North India. Indian Journal of Endocrinology and Metabolism. 16(7). 127–127. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026